InMed Pharmaceuticals
Investor Insight InMed is a pharmaceutical drug development company advancing proprietary small-molecule drugs in Alzheimer’s and ophthalmology, backed by a...
Read moreInvestor Insight InMed is a pharmaceutical drug development company advancing proprietary small-molecule drugs in Alzheimer’s and ophthalmology, backed by a...
Read moreAstral Resources (AAR:AU) has announced Theia In-fill – Multiple High-Grade Zones of Gold Download the PDF here. This post appeared...
Read moreGreen Technology Metals(GT1:AU) has announced Ontario Lithium Project Development Update Download the PDF here. This post appeared first on investingnews.com
Read moreGraphite One (TSXV:GPH,OTCQX:GPHOF) announced on November 13 that it has identified rare earth elements (REEs) at its Graphite Creek deposit,...
Read moreResearchers have documented the first known recovery of naturally formed nanoscale monazite from a living plant, potentially opening up new...
Read moreEast Star Resources (LSE:EST) and Endeavour Exploration announced they have entered into a binding earn-in and joint venture (JV) agreement...
Read moreRio Tinto (ASX:RIO,NYSE:RIO,LSE:RIO) said on Monday (November 17) that it has signed a joint development agreement with environmental technology company...
Read moreWalmart announced Friday that longtime CEO Doug McMillon will retire at the end of January — which came as a...
Read morePerth, Australia (ABN Newswire) – Locksley Resources Ltd (ASX:LKY,OTC:LKYRF) (FRA:X5L) (OTCMKTS:LKYRF) announced it has formalised a research collaboration with Columbia...
Read moreLocksley Resources Ltd (ASX: LKY, OTCQX: LKYRF, FSE: X5L) (“Locksley” or the “Company”), is pleased to announce it has formalised...
Read more